ReviewCurrent oncology (Toronto, Ont.)2022

Optimal Choice as First-Line Therapy for Patients with Triple-Negative Breast Cancer: A Bayesian Network Meta-Analysis.

Yiqun Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.